欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DK/H/3117/001
药品名称Clobazam Essential Pharmaceuticals
活性成分
    • clobazam 1.0 mg/ml
剂型Oral suspension
上市许可持有人Essential Pharmaceuticals Limited Vision Exchange Building, Triq It-Territorjals Zone 1, Central Business District CBD 1070 Birkirkara Malta
参考成员国 - 产品名称Denmark (DK)
互认成员国 - 产品名称
    • Belgium (BE)
      Clobazam Essential Pharmaceuticals 1 mg/ml suspension buvable
    • Netherlands (NL)
    • Luxembourg (LU)
    • Ireland (IE)
    • Austria (AT)
      Clobazam Essential Pharmaceuticals 1 mg/ml Suspension zum Einnehmen
    • Norway (NO)
      Clobazam Essential Pharmaceuticals
    • Finland (FI)
    • United Kingdom (Northern Ireland) (XI)
许可日期2021/08/19
最近更新日期2021/11/29
药物ATC编码
    • N05BA09 clobazam
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase